Intuitive Surgical, Inc. (NASDAQ:ISRG) Receives a Buy from Canaccord Genuity

Canaccord Genuity analyst Jason Mills reiterated a Buy rating on Intuitive Surgical, Inc. (NASDAQ: ISRG) today and set a price target of $615. The company’s shares closed yesterday at $505.09.

Intuitive Surgical has an analyst consensus of Moderate Buy, with a price target consensus of $585.

Based on Intuitive Surgical`s latest earnings report from March 31, the company posted quarterly revenue of $532.1M and quarterly net profit of $97M. In comparison, last year the company earned revenue of $512.2M and had a net profit of $104M.

Financial bloggers on sites such as SeekingAlpha, the MotleyFool and others, seem to have a Positive view on ISRG. When evaluating the opinions of financial bloggers over the last 3 months, 66% of bloggers have indicated a Bullish sentiment, while 34% have indicated a Bearish sentiment. The average blogger Bullish sentiment in the sector is 67% which is slightly more positive than the blogger sentiment of ISRG.

Unlike Canaccord Genuity`s latest rating, based on the recent corporate insider activity of 66 insiders, corporate insider sentiment is neutral on the stock. Last month, Alan J. Levy, a director at ISRG sold 417 shares for a total of $206,586.

According to TipRanks.com, Mills is a 3-star analyst with an average return of 3.1%and a 49.7% success rate. Mills covers the Healthcare sector, focusing on stocks such as Trivascular Technologies, Staar Surgical Company, and Edwards Lifesciences.

Intuitive Surgical Inc designs, manufactures and markets da Vinci Surgical Systems and related instruments and accessories.